...
首页> 外文期刊>Journal of Surgical Research: Clinical and Laboratory Investigation >RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence
【24h】

RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence

机译:RT-PCR的腹膜洗涤预测腹膜胰腺癌复发

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundPeritoneal recurrence of pancreatic cancer is a frequent and lethal outcome after R0 resection. A method to predict peritoneal recurrence could be helpful in its prevention. Materials and methodsPeritoneal washings were prospectively obtained from 29 patients in whom R0 resection was performed. Cytological examination (CY) and real-time reverse transcription polymerase chain reaction (RT-PCR) of the peritoneal washing for the detection of cancer-related genes, CEACAM5, KRT7, KRAS, and MUC1, were performed. Clinicopathological characteristics and real-time RT-PCR results of the peritoneal washing were compared between patients whose pancreatic cancer recurred peritoneally (n?=?7) and those patients who it did not recur (n?=?22). ResultsOnly one CY-positive (CY+) case was detected, and that patient recurred. MUC1 mRNA expression was significantly higher in the recurrence group (P?=?0.015). Cumulative incidence-function analysis demonstrated that peritoneal recurrence rate was significantly higher in MUC1-positive (MUC1+) patients (P?=?0.044). MUC1+patients had significantly decreased disease-free survival (P?=?0.009) and disease-specific survival (P?=?0.031). MUC1 protein was detected in the primary tumor in 18 of 29 patients. However, no significant difference was observed in the expression of MUC1 protein in peritoneal washings from the primary tumor (P?=?0.579). ConclusionsHigh expression of MUC1 mRNA in peritoneal washings is a significant risk factor for peritoneal recurrence of pancreatic cancer after R0 resection along with poor disease-specific survival. RT-PCR of MUC1 mRNA in peritoneal washing may be useful for individualization of adjuvant chemotherapy.
机译:胰腺癌的背景是R0切除后常心和致命的结果。预测腹膜复发的方法可能有助于预防。从预期的29名患者进行了预期获得的材料和拟人洗涤术。进行细胞学检查(CY)和实时逆转录聚合酶链反应(RT-PCR)用于检测癌症相关基因,CEACAM5,KRT7,KRA和MUC1的腹膜洗涤。在胰腺癌重复的患者中比较了腹膜洗涤的临床病理特征和实时RT-PCR结果(n?=?7)和那些它没有重现的患者(n?= 22)。结果检测到一种含有一种含量的含量,患者重复。复发组中MUC1 mRNA表达显着高(P?= 0.015)。累积发病率分析表明,MUC1阳性(MUC1 +)患者腹膜复发率显着高(P?= 0.044)。 MUC1 +患者的无病生存率显着降低(p?= 0.009)和疾病特异性存活(p?= 0.031)。在29例患者中,在原发性肿瘤中检测到MUC1蛋白。然而,在来自原发性肿瘤的腹膜洗涤中的MUC1蛋白表达中没有观察到显着差异(P?= 0.579)。结论HUC1 mRNA在腹膜洗涤中的表达是R0切除后胰腺癌腹膜复发的显着危险因素,以及疾病特异性差的存活率。腹膜洗涤中的MUC1 mRNA的RT-PCR可用于辅助化疗的个体化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号